Original Source(s)
Related Content
Correction: Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis
August 1, 2026
Cancer Detection: The e-Nose Knows
Emerging e-nose technology analyzes chemical signatures from breath and skin to support cancer diagnosis
August 3, 2026
-
3 min
FDA Approves Melanoma BRAF Companion Test
The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.
August 10, 2026
-
1 min